University Hospital Zurich, Division of Internal Medicine
Zurich, Canton of Zurich, 8091, Switzerland
NCT Number: NCT01683487
I. To investigate time measurement from emergency room admission to first antibiotic administration.
II. To evaluate risk factors for prolonged time to first antibiotic administration.
III. To correlate time measurement with Charlson comorbidity index and multimorbidity patterns.
IV. To investigate the impact of a delayed time to first antibiotic administration on the outcome
Looking for future studies?
Notify Me16 year and older
All sexes
Observational
Zurich, Canton of Zurich, 8091, Switzerland
In this retrospective cohort study, we plan to include all patients presenting with a community-acquired pneumococcal pneumonia at the University Hospital of Zurich between January 1, 2006 and June 30, 2012 (6½ years). The patients will be identified either with one or more blood culture pairs positive for S. pneumoniae or with a positive pneumococcal urine antigen assay in combination with the clinical diagnosis of CAP, which was based on the presence of select clinical features (e.g., cough, fever, sputum production, and pleuritic chest pain) and is supported by imaging of the lung, usually by chest radiography according to Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of CAP in adults [11].
CAP is not considered if the patient is discharged from a hospital less than 7 days before the current hospital admission, if the first blood culture or urinary antigen assay is obtained more than 1 week after hospital admission, or if the patient has no clinical diagnosis of CAP at the time of admission. Patients referred from or transferred to another hospital are excluded.
After identification of eligible patients upon microbiological results, medical records are reviewed using a standardized data collection questionnaire. Comorbidity is determined using the Charlson comorbidity index [10]. Additionally, all patients are classified according to the multimorbidity patterns proposed by Holden et al. [12]. These are:
Time calculation is based upon the moment of emergency room (ER) admission.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Patients with community-acquired pneumococcal pneumonia, which was confirmed by
Exclusion criteria
- Pneumonia of other cause (e.g. non-pneumococcal pneumonia)
Observational study only, no intervention.
Time frame: From day of admission until discharge or dead
Mortality during hospitalization because of pneumococcal pneumonia
University of Zurich
Other
Delayed Antibiotic Treatment in Community-acquired Pneumococcal Pneumonia. Analysis of Risk Factors and Impact on the Outcome.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05568654
Antimicrobial Stewardship, Community-Acquired Infections
Vero Beach, Florida, United States
View Trial DetailsNCT05452226
COPD Exacerbation Acute, Community-Acquired Infections
Burlington, Vermont, United States
View Trial DetailsNCT05962606
Community-Acquired Infections, Community-Acquired Pneumonia
Birmingham, Alabama, United States
View Trial DetailsNCT06272994
Community-Acquired Infections, Community-Acquired Pneumonia
Nashville, Tennessee, United States
View Trial Details